City Therapeutics raises $200M in IPO to advance next-gen RNAi drugs
The startup, co-founded by Alnylam's former CEO, will fund clinical trials for RNAi therapies targeting clotting, eye disease, and anemia.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
CDC survey finds 40% of US high schoolers report binge eating
The first Youth Risk Behavior Survey question on binge eating in a decade reveals the behavior is widespread and more common among female students and youth of color.
New ACOG Guidelines Strongly Recommend Early Menopause Hormone Therapy
Updated ACOG guidelines align with other societies in strongly recommending early hormone therapy for menopausal symptoms, marking a shift in clinical consensus.
Nursing shortage fix requires better workplaces, not just more nurses
A nurse-researcher argues, after her daughter's death in a group home, that the healthcare workforce crisis is a design failure rooted in poor working conditions and invisible care workers.
Employers urged to start 2028 health benefits planning in early 2027
A Marsh McLennan advisor says early planning, better management of high-cost claimants, and genomic testing can help curb rising employer healthcare costs.
FDA Approves First OTC Eye Drop for Redness: Apraclonidine 0.125%
The approval gives consumers a nonprescription alpha-agonist option for managing minor eye irritation, with safety limits on dosing and wearers of contacts given specific instructions.
Epic to Launch Prescription Price Comparison Tool in 2027
Epic's upcoming tool will let patients compare cash and insurance prices for prescriptions across pharmacies.
Sickle Cell Survival Triples, Yet Gene Therapy Reaches Few
Adults with sickle cell disease now live decades longer than in the 1970s, thanks to gene therapy and more proactive comprehensive care, though access remains uneven.
Xilio Therapeutics names Yariv Houvras chief medical officer
Xilio Therapeutics has appointed Yariv Houvras, a biotech oncology executive, as its new chief medical officer.
Moderna’s sixfold surge and Roche’s China deal spree top biotech charts
A BioPharma Dive analysis charts Moderna’s pandemic-like stock run after a pivotal melanoma vaccine readout and Roche’s sudden lead in China licensing.
Anti-CGRP Migraine Drugs Linked to Higher Miscarriage Risk
A new U.S. study found that anti-CGRP monoclonal antibodies for migraine prevention were associated with a 42% higher risk of spontaneous abortion, while propranolol was not.
Health Systems Face End of Cross-Subsidization
The traditional model of using profitable services to cover losses is becoming unsustainable, pushing health systems to find new strategies.
RevMed pancreatic cancer drug nears European approval, STAT reports
STAT's newsletter signals a potential European approval for RevMed's pancreatic cancer drug, a notable step for a hard-to-treat malignancy.
First At-Home Thyroid Eye Disease Treatment Wins FDA Approval
Self-administered satralizumab offers a new subcutaneous option for thyroid eye disease, though one pivotal trial missed its primary endpoint.
FDA Reviews Keytruda Biosimilar as Oncology Roundup Shows Mixed Trial Results
A single-source oncology update highlights regulatory progress on a Keytruda biosimilar, positive radiopharmaceutical data, and a failed mRNA cancer vaccine trial.
Polar Bears in Greenland Test Positive for H5N1 Bird Flu
Detection of highly pathogenic avian influenza in Arctic marine mammals raises concerns about viral spread and reassortment.
AI Unifies MedTech Data While Keeping Compliance Intact
A connected, agent-ready enterprise model lets medical technology companies pair regulatory compliance with AI-driven data intelligence.
Medical Societies Speak Out Against RFK Jr.'s Anti-Vaccine Stance and AI Claims
Physician groups are dropping their cautious tone to publicly challenge HHS Secretary Robert F. Kennedy Jr., from his handling of measles to his suggestion that AI could outperform doctors.